Arcturus Therapeutics Holdings Overview
Arcturus Therapeutics Holdings Target Price
Analysts' 12-month price predictions for ARCT.
Share Price
$17.85
Average Target Price
$43.00
140.9% upside
140.9% upside2 analysts in the last 4 months
High: $54 | Low: $32
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-22 | Leerink PartnersLili Nsongo | $54 | 202.5% upside |  |
| 2025-05-28 | ScotiabankGreg Harrison | $32 | 79.3% upside | |
| 2025-03-10 | BTIGThomas Shrader | $48 | 168.9% upside | |
| 2024-11-11 | Canaccord GenuityWhitney Ijem | $10.58 |  40.7% downside | |
| 2024-08-06 | Canaccord GenuityWhitney Ijem | $10.3 | 42.3% downside | |
| 2024-07-02 | H.C. WainwrightEd Arce | $8.58 | 51.9% downside | |
| 2024-05-31 | Piper SandlerYasmeen Rahimi | $20.02 | 12.2% upside | |
| 2024-05-10 | Canaccord GenuityWhitney Ijem | $12.3 | 31.1% downside | |
| 2024-03-19 | LaidlawYale Jen | $11.3 | 36.7% downside | |
| 2022-11-02 | BarclaysGena Wang | $25 | 40.1% upside | |
| 2022-05-11 | Goldman Sachs | $14 | 21.6% downside | |
| 2021-11-09 | Goldman SachsMadhu Kumar | $30 | 68.1% upside | |